(Q40633180)

English

Receptor Activator of NF-κB Ligand Stimulates Recruitment of SHP-1 to the Complex Containing TNFR-Associated Factor 6 That Regulates Osteoclastogenesis

scientific article published on October 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Receptor Activator of NF-κB Ligand Stimulates Recruitment of SHP-1 to the Complex Containing TNFR-Associated Factor 6 That Regulates Osteoclastogenesis (English)

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

0 references

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

author name string

Zhiyuan Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Eijiro Jimi

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Alfred L. M. Bothwell

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14500659

12 March 2024

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

full work available at URL

Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

171

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

3620-3626

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice

2

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Protein tyrosine phosphatases in signal transduction.

3

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1

4

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1

5

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis

6

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1

7

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation

8

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation

9

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells

10

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix

11

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

12

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

13

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

14

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

16

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

17

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death

18

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Requirement for NF-kappaB in osteoclast and B-cell development

19

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif

20

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily

21

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

22

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src

23

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation.

24

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene

25

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice

26

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density

27

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

c-myc is required for osteoclast differentiation

28

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro

29

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Cytoprotection of human umbilical vein endothelial cells against apoptosis and CTL-mediated lysis provided by caspase-resistant Bcl-2 without alterations in growth or activation responses

32

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

33

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development

34

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B

35

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures

36

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor

37

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

38

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity

39

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function

40

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

41

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β

42

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis

43

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Intramolecular regulation of protein tyrosine phosphatase SH-PTP1: a new function for Src homology 2 domains

44

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Murine SHP-1 splice variants with altered Src homology 2 (SH2) domains. Implications for the SH2-mediated intramolecular regulation of SHP-1.

45

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1.

46

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Binding of phosphatidic acid to the protein-tyrosine phosphatase SHP-1 as a basis for activity modulation

48

1 reference

10.4049/JIMMUNOL.171.7.3620

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3620

12 March 2024

Identifiers

10.4049/JIMMUNOL.171.7.3620

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40633180&oldid=2101993578"